Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.5B; returns 1 day -2.1%, 1 week +2.5%, 1 year -14.7%.

Beam Therapeutics is a biotechnology company focused on precision genetic medicines using its base editing technology. Their approach modifies single DNA letters without cutting the double helix, potentially offering safer and more precise treatments for genetic diseases. Beam operates a fully integrated platform, combining gene editing, delivery, and manufacturing.

Groups BEAM belongs to

• Biotechnology
• Healthcare
• Gene Therapy
• Biopharmaceutical
• Precision Medicine
• Clinical Stage
• Clinical Stage Biotech
• Sickle Cell Disease
• Hematology
• Life Sciences
• Autologous Cell Therapy
• Rare Diseases

BEAM financial model: income statement, cash flow and balance sheet